European Research Council Advanced Investigators Grant - Call for Proposals
Life Sciences - deadline 17 March
EASL welcomes UK consultation on alcoholic drinks labels
Deadline for responses to the consultation: 9 May
2010 Call for proposals: New funding opportunities in health
European Executive Agency for Health and Consumers calls for proposals. Submission deadline: March 19
Press releases
2009-10-26
EASL website launch October 2009
The European Association for the Study of the Liver
Dear colleague, dear friend, As 2010 approaches, EASL moves forward into the golden electronic era.  On this occasion, we would like to update you on the new EASL website launch. Our association, the European Association for the Study of the Liver, has become a leading society [...] Read more
2009-07-04
Best of EASL 2009 China Tour and EASL guidelines in China
Profs. Jean-Michel Pawlotsky, Peter LM Jansen, Massimo Pinzani
Images, more information and press release available here: http://www.emd-asia.com/ESAL_Tour/press_Release.html http://www.emd-asia.com/easl_guideline/index.html Read more
2009-06-19
EASL Clinical Practice Guidelines: Management of cholestatic liver diseases
European Association for the Study of the Liver
Volume 51, No 2.   In October 2008, the European Association for the Study of the Liver (EASL) proudly published its first Clinical Practice Guidelines on the “Management of chronic hepatitis B”. Just eight months later, Europe's leading association of medical [...] Read more
2009-05-25
The Liver is Life
Professor Dominique Valla, EASL EU Policy Counsellor
The article by Professor Dominique Valla published in ‘The Parliament Magazine’, Policy, Politics and People, Issue 289, shows that contrary to common belief, liver disease is not always a self inflicted disease. It is caused by a conjunction of several conditions, which have [...] Read more
2008-11-30
First EASL Clinical Practice Guidelines on Management of Chronic Hepatitis B
The European Association for the Study of the Liver
Worldwide, hepatitis B virus is a major cause of liver disease (acute and chronic hepatitis, cirrhosis and liver cancer). Approximately, 350 million individuals are infected. According to WHO, hepatitis B virus infection caused 750 000 deaths in 2000. European countries are far [...] Read more
2008-05-19
EASL endorses 12 “Asks” in the fight against viral hepatitis
EASL and ELPA
World Hepatitis Day 2008: "Am I Number 12?" Read more
2008-04-27
Molecular discoveries shed light on liver cancer - Hepatocellular Carcinoma (HCC)
The European Association for the Study of the Liver
Genomics improves our ability to target experimental cancer treatments. A promising new drug is in hand, and more are on the way. Improved ability to select patients to test particular drugs. Read more
2008-04-26
Basic science discoveries yield progress in hepatology
The European Association for the Study of the Liver
Advances in virology translate into new promising drugs to combat Hepatitis C. Clarification of oncogenic pathways aids liver cancer research. Stem cells of potential benefit in liver transplantation. Systems biology helps to solve complex liver diseases. Read more
2008-04-25
Important progress toward control of Hepatitis B and C
The European Association for the Study of the Liver
Positive test results for new drugs against Hepatitis C. Improved screening for Hepatitis C reflects physicians' optimism. New drugs effective against Hepatitis B, but patient selection necessary. Read more
2008-04-24
NAFLD and NASH linked to metabolic syndrome and cardiovascular disease
The European Association for the Study of the Liver
Patients with fatty liver are at increased risk of cardiovascular disease. Prevalence estimates vary widely and approach 25% among adults. Risk factors for fatty liver include overweight type 2 diabetes and sedentary lifestyle. Read more